Results for
"[search-keyword]"
Sponsor content
271 result(s) found, displaying 1 to 10
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Ertapenem-AFT ertapenem (as sodium) 1 g powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ferro-f-tab tablet blister (new formulation).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ferro-tab tablet blister (new formulation).
-
Prescription medicine registrationActive ingredients: Ertapenem sodium.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFT PHARMACEUTICALS PARACETAMOL & CAFFEINE TAB film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFT PHARMACEUTICALS PARACETAMOL & CAFFEINE SOFT GEL CAPS soft capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LORAZEPAM-AFT lorazepam 4 mg/1 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEROPENEM-AFT meropenem (as trihydrate) 1000 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEROPENEM-AFT meropenem (as trihydrate) 500 mg powder for injection vial.